# Efficacy and Safety of SOM3355 in Huntington's Disease Chorea

> **NCT03575676** · PHASE2 · COMPLETED · sponsor: **SOM Innovation Biotech SA** · enrollment: 32 (actual)

## Conditions studied

- Huntington's Chorea

## Interventions

- **DRUG:** SOM3355 100mg BID
- **DRUG:** SOM3355 200mg BID
- **DRUG:** Placebo BID

## Key facts

- **NCT ID:** NCT03575676
- **Lead sponsor:** SOM Innovation Biotech SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-08
- **Primary completion:** 2019-08-22
- **Final completion:** 2019-08-22
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575676, "Efficacy and Safety of SOM3355 in Huntington's Disease Chorea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03575676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*